An evaluation of transient elastography in the discrimination of HBeAg‐negative disease from inactive hepatitis B carriers

Summary.  Liver biopsy is frequently required in HBeAg‐negative disease to determine the stage of fibrosis. It can be difficult to distinguish cohorts with undetectable HBeAg who may have varying degrees of fibrosis due to different stages of disease. We have assessed the utility of transient elastography (TE) to evaluate differences in HBeAg‐negative patients. A total of 220 HBsAg‐positive individuals were studied: 125 (group 1) had an inactive HBsAg carrier state and 95 (group 2) were HBeAg‐negative, anti‐HBe‐positive patients with persistently or intermittent elevation of alanine aminotransferase (ALT) and/or HBV DNA >105 copies/mL. Mean stiffness was 4.83 ± 1.2 kPa in group 1 vs 8.53 ± 6 kPa in group 2 (P < 0.001); statistically significant differences were also found between AST/ULN ALT/ULN ratios, HBV DNA in group 1 vs group 2, respectively (P < 0.001). In the multivariate analysis, the only variable independently associated with the stage of fibrosis was the stiffness. This study shows that mean hepatic stiffness by elastography is significantly lower in patients with inactive hepatitis B compared to those with HBeAg‐negative disease. The procedure is a useful adjunct to diagnosis to confirm a clinical pattern of disease, and for more selective use of liver biopsy before considering antiviral therapy.

[1]  M. Brunetto,et al.  Liver stiffness in the hepatitis B virus carrier: a non-invasive marker of liver disease influenced by the pattern of transaminases. , 2008, World journal of gastroenterology.

[2]  Laurent Castera,et al.  Non-invasive evaluation of liver fibrosis using transient elastography. , 2008, Journal of hepatology.

[3]  S. Czernichow,et al.  Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome. , 2008, Journal of hepatology.

[4]  J. Hayashi,et al.  Transient elastography for patients with chronic hepatitis B and C virus infection: Non‐invasive, quantitative assessment of liver fibrosis , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

[5]  Ding‐Shinn Chen,et al.  Hepatitis B viral factors in HBeAg‐Negative carriers with persistently normal serum alanine aminotransferase levels , 2007, Hepatology.

[6]  A. Nakajima,et al.  Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD) , 2007, Gut.

[7]  M. Ziol,et al.  Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC , 2006, Hepatology.

[8]  Guan-Tarn Huang,et al.  Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. , 2006, JAMA.

[9]  D. Wong,et al.  Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications , 2005, Gut.

[10]  V. de Lédinghen,et al.  Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. , 2005, Gastroenterology.

[11]  M. Rugge,et al.  Liver biopsy sampling in chronic viral hepatitis. , 2004, Seminars in liver disease.

[12]  V. Paradis,et al.  Sampling variability of liver fibrosis in chronic hepatitis C , 2003, Hepatology.

[13]  M. Ziol,et al.  Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. , 2003, Ultrasound in medicine & biology.

[14]  S. Sarin,et al.  Hepatitis B e‐antigen negative chronic hepatitis B , 2002, Journal of gastroenterology and hepatology.

[15]  H. Kim,et al.  Effect of virological response on post‐treatment durability of lamivudine‐induced HBeAg seroconversion , 2002, Journal of viral hepatitis.

[16]  D. Vassilopoulos,et al.  Hepatitis B e antigen–negative chronic hepatitis B , 2001, Hepatology.

[17]  G. Norkrans,et al.  Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B , 2000, Journal of viral hepatitis.

[18]  M. Colombo Epidemiology of hepatocellular carcinoma. , 1995, The Italian journal of gastroenterology.

[19]  F Tsuda,et al.  Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen , 1994, Journal of virology.

[20]  P. Scheuer,et al.  Classification of chronic viral hepatitis: a need for reassessment. , 1991, Journal of hepatology.

[21]  J. Hoofnagle,et al.  Spontaneous reactivation of chronic hepatitis B virus infection. , 1984, Gastroenterology.

[22]  J. Hoofnagle,et al.  Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis. , 1981, Annals of internal medicine.

[23]  M. J. Campbell Prospective Comparison of Transient Elastography, Fibrotest, APRI, and Liver Biopsy for the Assessment of Fibrosis in Chronic Hepatitis CCastéra L, Vergniol J, Foucher J, et al (Hôpital Haut Lévêque, Bordeaux, Pessac, France; Hôpital Pellegrin, Bordeaux, France; Université Victor Segalen, Bordeaux, , 2006 .

[24]  J. Bruzzi,et al.  Liver biopsy. , 2001, The New England journal of medicine.